GSK to cut jobs as part of £1.9bn cost-cutting plan to speed drug development
GSK announced job cuts as part of a £1.9 billion cost-cutting initiative aimed at streamlining operations and accelerating drug development. The pharmaceutical giant's restructuring plan seeks to improve efficiency and reduce expenses to boost innovation. This matters because it signals significant workforce reductions and a strategic shift in focus to faster drug pipelines.